Biohit

2.66 EUR

-0.37%

4,934 following
Corporate customer

BIOBV

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Valuation

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Biohit

P/E (adj.)

Median 2021-2025

EV/S

Median 2021-2025

EV/EBIT (adj.)

Median 2021-2025

Dividend yield

Median 2021-2025

P/B

Median 2021-2025

 
20192020202120222023202420252026e2027e2028e2029e
Share price (EUR)3.362.481.841.571.922.293.692.662.662.662.66
Shares15.015.015.015.015.115.115.215.215.215.215.2
Market cap50.637.327.723.629.034.656.140.440.440.440.4
Enterprise value41.931.622.318.324.529.854.032.730.929.227.4
EV/S4.24.42.41.71.92.13.41.91.71.41.1
EV/EBITDA70.5neg.44.011.411.710.415.910.56.75.74.5
EV/EBIT (adj.)neg.neg.neg.16.314.012.218.612.510.38.96.6
EV/EBITneg.neg.neg.16.314.012.218.612.510.38.96.6
P/E (adj.)neg.neg.neg.39.316.612.920.818.215.814.511.5
P/Eneg.neg.neg.39.316.612.920.818.215.814.511.5
P/B3.44.23.83.13.12.83.72.32.11.91.7
P/S5.05.23.02.22.22.43.62.42.21.91.6
Dividend yield0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %0.0 %1.7 %1.9 %2.1 %4.3 %
Equity ratio84.4 %81.6 %76.7 %68.7 %73.1 %79.0 %76.0 %92.4 %92.4 %92.2 %91.9 %
Gearing ratio-59.2 %-64.7 %-72.4 %-69.8 %-47.6 %-39.6 %-14.0 %-44.8 %-49.9 %-52.9 %-54.6 %